Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section

ConditionTransversalis Fascia Plane Block

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

AgeNot listed

SponsorTanta University

About this trial

Evaluate calcitonin as an adjuvant to bupivacaine in ultrasound guided tansversalis fascia plane block

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

female pt ASA2 scheduled for cs under spinal anesthesia

Disqualifiers

patient refusal ASAmore than 3 patients with pregnancy related disease emergency cs history of coagulopathy

Trial design

Design model

Sequential

Treatments tested in this trial

us guided Transversalis fascia plane block
Other intervention
addition of calcitonin to pubivacaine

Treatment groups

70 Participants

are divided into 2 treatment groups

Group A: Transversalis fascia plane block with bupivacaineActive comparator 1 intervention

Group B: Transversalis fascia plane block with calcitonin and bupivacaineActive comparator 1 intervention

Trial outcomes

Primary outcomes

time to first rescue analgesia

Time frame

24 hours

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tanta University

Lead sponsor

Source ClinicalTrials.gov

Apply now